Sponsor Improves Patient Recruitment in Rare Disease Clinical Trial
Downloadable Case Study
A Mid-sized Sponsor Increased Site Count by 50% in a Rare Disease Clinical Trial with Medidata AI Intelligent Trials
As they embarked on an upcoming rare disease clinical trial, a mid-sized biopharmaceutical company was struggling with clinical trial patient recruitment and site selection. Between 2016 and 2020, over a quarter of rare disease trials were terminated due to low patient accrual rates. In such a challenging indication, it was critical for this mid-sized sponsor to choose high-performing trial sites based on reliable data to set their trial up for success.
Download this case study to see how Medidata AI helped this sponsor with:
- Site recommendations based on the sponsor’s key priority metrics, including operational performance
- Robust data quality metrics
- A comparison of their historical performance benchmarked against the industry